Zai Lab Announces the Inclusion of AUGTYRO® (repotrectinib) for ROS1+ NSCLC and Other ...
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the 2024 National Reimbursement Drug List (NRDL) released by China’s National Healthcare Security Administration (NHSA) has been updated ...
India Infoline9 小时
Shilpa Medicare’s JV Oncosol Gets FDA Nod for IMKELDI
Shilpa Medicare’s joint venture Oncosol, with Shorla Oncology, has gained US FDA approval for IMKELDI, an imatinib oral ...
Managed Healthcare Executive1 天
FDA Approves New Imatinib Oral Solution
Imkeldi is a new formulation of imatinib approved as a strawberry-flavored, shelf-stable liquid designed to be more appealing ...
Targeted Oncology2 天
FDA Approves First Oral Liquid Imatinib for Leukemia and Other Cancers
Imatinib oral solution has gained FDA approval for the treatment of some cancers, including certain forms of leukemia.
Kura Oncology, Inc. (KURA): Among the Most Promising Cancer Stocks According to Hedge Funds
We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In this article, we are going to ...